| 翻訳と辞書 |
| Eugene Goldwasser ： ウィキペディア英語版 |
Eugene Goldwasser
Eugene Goldwasser (October 14, 1922 – December 17, 2010) was an American biochemist at the University of Chicago who identified erythropoietin (widely known as EPO or Epo), a hormone that plays a vital role in the synthesis of red blood cells. After sharing the minute quantities that he had been able to isolate with researchers at the biotechnology firm Amgen, that company was able to use genetic engineering technology to produce useful amounts of EPO as a drug to treat anemia that has achieved substantial financial success, but that has also been used by athletes as a performance-enhancing drug.
==Early life and education==
Goldwasser was born on October 14, 1922, in Brooklyn, New York, and moved with his family to Kansas City, Missouri following the collapse of his father's clothing company.〔Pollack, Andrew. ("Eugene Goldwasser, Biochemist Behind an Anemia Drug, Dies at 88" ), ''The New York Times'', December 20, 2010. Accessed December 27, 2010.〕 He received a scholarship to attend the University of Chicago and worked at the school's defense-oriented toxicity laboratory during World War II before earning his undergraduate degree in biochemistry in 1943.〔Ramirez, Margaret. ("Dr. Eugene Goldwasser, 1922-2010: Biochemist behind lifesaving drug, father of EPO" ), ''Chicago Tribune'', December 21, 2010. Accessed December 27, 2010.〕 Goldwasser served for two years at Fort Detrick, home of the United States biological weapons program, studying anthrax after being drafted by the United States Army in 1944.〔 He earned his doctorate in biochemistry in 1950 after returning to the University of Chicago.〔
抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』
■ウィキペディアで「Eugene Goldwasser」の詳細全文を読む
スポンサード リンク
| 翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|